Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben F Ørntoft

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
BMC Bioinformatics|December 31, 2005
Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosisNils E Magnusson, Alessandra K Cardozo, Mogens Kruhøffer, et al.
BJU International|January 19, 2016
Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressivenessTine M Storebjerg, Søren Høyer, Pia Kirkegaard, et al.
Oncogene|September 14, 2004
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancerJirina Bartkova, Per Guldberg, Kirsten Grønbaek, et al.
BMC Cancer|November 3, 2009
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progressionFrederikke Lihme Egerod, Annette Bartels, Niels Fristrup, et al.
Clinical Epigenetics|August 9, 2018
Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancerTine Maj Storebjerg, Siri H Strand, Søren Høyer, et al.
The Journal of Pathology|November 8, 2012
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancersMichal Cohen-Eliav, Regina Golan-Gerstl, Zahava Siegfried, et al.
Bioinformatics (Oxford, England)|August 15, 2002
Neural network predicts sequence of TP53 gene based on DNA chipJeppe S Spicker, Friedrik Wikman, Ming-Lan Lu, et al.
Plos Medicine|February 8, 2020
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trialJacob Fredsøe, Jan Koetsenruyter, Peter Vedsted, et al.
Molecular Oncology|February 22, 2018
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsiesChrista Haldrup, Anne L Pedersen, Nadia Øgaard, et al.
European Urology Focus|July 30, 2017
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free UrineJacob Fredsøe, Anne K I Rasmussen, Anni R Thomsen, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
BMC Bioinformatics|December 31, 2005
Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosisNils E Magnusson, Alessandra K Cardozo, Mogens Kruhøffer, et al.
BJU International|January 19, 2016
Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressivenessTine M Storebjerg, Søren Høyer, Pia Kirkegaard, et al.
Oncogene|September 14, 2004
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancerJirina Bartkova, Per Guldberg, Kirsten Grønbaek, et al.
BMC Cancer|November 3, 2009
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progressionFrederikke Lihme Egerod, Annette Bartels, Niels Fristrup, et al.
Clinical Epigenetics|August 9, 2018
Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancerTine Maj Storebjerg, Siri H Strand, Søren Høyer, et al.
The Journal of Pathology|November 8, 2012
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancersMichal Cohen-Eliav, Regina Golan-Gerstl, Zahava Siegfried, et al.
Bioinformatics (Oxford, England)|August 15, 2002
Neural network predicts sequence of TP53 gene based on DNA chipJeppe S Spicker, Friedrik Wikman, Ming-Lan Lu, et al.
Plos Medicine|February 8, 2020
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trialJacob Fredsøe, Jan Koetsenruyter, Peter Vedsted, et al.
Molecular Oncology|February 22, 2018
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsiesChrista Haldrup, Anne L Pedersen, Nadia Øgaard, et al.
European Urology Focus|July 30, 2017
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free UrineJacob Fredsøe, Anne K I Rasmussen, Anni R Thomsen, et al.
Pageof 8